Table 2. Levels of pulmonary thromboembolism, comorbidity and reasons of treatment preferences.
UCSD classification | Comorbidity | Reasons of treatment preferences | ||
Case 1 | 71F | III | Rectal cancer | Old age, comorbidity, difficult surgical accessibility |
Case 2 | 53M | III | Protein S deficiency, HTN | Difficult surgical accessibility |
Case 3 | 54M | III | CAD, HTN, DM | Difficult surgical accessibility |
Case 4 | 53F | IV | ESRD, HTN, dyslipidemia | Comorbidities, difficult surgical accessibility |
Case 5 | 76F | III | APS, HTN | Old age, comorbidities, difficult surgical accessibility |
Case 6 | 44F | III | HTN, DM, dyslipidemia | Patient refused PEA, difficult surgical accessibility |
Case 7 | 44F | III | APS | Comorbidity, difficult surgical accessibility |
Case 8 | 55F | III | - | Patient refused PEA, difficult surgical accessibility |
Case 9 | 54F | III | AIHA | Patient refused PEA, difficult surgical accessibility |
Case 10 | 71F | III | HTN | Old age, difficult surgical accessibility |
Case 11 | 66M | IV | - | Patient refused PEA, difficult surgical accessibility |
The definition of UCSD classification: level 0: no evidence for CTEPH; level I: disease involved one of the main pulmonary arteries; level II: disease involved the lobar branches or past the takeoff of the upper lobe artery; level III: disease is distal and started from the segmental branches; level IV disease: disease only involved the subsegmental branches.19
AIHA, autoimmune hemolytic anemia; APS, antiphospholipid syndrome; CAD, coronary artery disease; DM, diabetes mellitus; ESRD, end stage renal disease; HTN, hypertension; PEA, pulmonary endarterectomy; UCSD, University of California, San Diego.